comparemela.com

Nexalin Gen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nexalin Technology Announces Regulatory Approval to Sell Nexalin s Gen-2, 15 mA | Region

HOUSTON, TX, June 13, 2024 (GLOBE NEWSWIRE) Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that its second generation (Gen-2), 15 milliamp (mA) neurostimulation device

United statesMark whiteNexalin genExchange commissionCompany report on formNexalin technologyCompany or nexalin nasdaqBrazilian health regulatory agencyCrescendo communicationsNexalin technology incRedchip companies incRisk factors

FDA OKs Trials for Nexalin s Sleep and Anxiety Therapy Headset

The FDA has agreed on the design for Nexalin's planned clinical studies of the Gen-3 HALO Clarity, targeting insomnia and anxiety.

David owensNexalin genMark whiteDrug administrationNexalin technology incNexalin technologyTechnology incStudies set

Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts

HOUSTON, TX, May 22, 2024 Nexalin Technology, Inc. is pleased to announce its new division, Nexalin America, has been selected to join the National Traumatic Brain Injury Registry Coalition ..

United statesJulie pawelczykMark whiteNexalin genNexalin americaCompany or nexalin nasdaqUs department of defenseAmerican academy of neurologyHuman servicesNational traumatic brain injuryRegistry coalitionPlayers associationCompany report on formCrescendo communicationsUs department of veterans affairsUnited states brain injury alliance

Join Nexalin Technology s Exclusive Live Investor Webinar and Q&A Session on May 23

Join Nexalin Technology s Exclusive Live Investor Webinar and Q&A Session on May 23
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesMark whiteNexalin genCompany report on formRedchip companies incExchange commissionCompany or nexalin nasdaqCrescendo communicationsNexalin technology incRedchip companiesVirtual clinicNexalin technologyRisk factorsChip companies

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

HOUSTON, TEXAS, April 25, 2024 Nexalin Technology, Inc. announced that the Company received notice from The Nasdaq Stock Market on April 23, 2024, notifying the Company that it has regained.

United statesMark whiteNexalin genCompany or nexalin nasdaqCrescendo communicationsExchange commissionCompany report on formRedchip companies incNexalin technology incNasdaq stock marketNasdaq ruleNexalin technologyRisk factors

vimarsana © 2020. All Rights Reserved.